TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence

Sara Blaine1, Eric Claus, Nicole Harlaar

  • 1Department of Psychology , University of Colorado, Boulder, Colorado 80309, USA. ra.blaine@colorado.edu

Abstract

Insights

Genetic variations in the tachykinin receptor 1 (TACR1) gene are linked to alcohol dependence (AD) symptoms and brain responses to alcohol cues. Specific TACR1 single nucleotide polymorphisms (SNPs) may influence neural activity and AD severity.

Area of Science:

  • Neurogenetics
  • Addiction Psychiatry
  • Molecular Psychiatry

Background:

  • The tachykinin receptor 1 (TACR1) gene is implicated in alcohol dependence (AD).
  • TACR1 antagonists show therapeutic potential in preclinical and clinical AD models.
  • Investigating TACR1 genetic variations is crucial for understanding AD's biological underpinnings.

Purpose of the Study:

  • To investigate the association between TACR1 single nucleotide polymorphisms (SNPs) and brain activity (BOLD response) to alcohol cues in heavy drinkers.
  • To examine the relationship between TACR1 SNPs and AD symptom severity using the Study of Addictions: Genetics and Environment Genome Wide Association study (SAGE GWAS) data.

Main Methods:

  • Examined TACR1 genotypes and neural responses during an alcohol cue-induced craving task in 326 individuals with alcohol use disorders.
  • Performed correlational analyses between 69 TACR1 SNPs and AD symptoms in the SAGE GWAS dataset.

Main Results:

  • Specific TACR1 SNPs (rs3771863, rs3755459, rs1106855) predicted blood oxygen level dependent (BOLD) activation in brain reward areas (medial prefrontal cortex, striatum, insula) in response to alcohol cues.
  • rs3771863 was also associated with AD symptom count and BOLD activation in the mesocorticolimbic pathway.

Conclusions:

  • Several TACR1 SNPs, located near gene extremities, show potential functional significance in AD.
  • rs1106855 warrants further investigation due to its location within a stop codon, suggesting a potential role in AD pathogenesis.